Deep understanding of the interaction between thienorphine and UDP-glucuronosyltransferase (UGT) isoforms

Xenobiotica

Volumn 43, Issue 2, 2013, Pages 133-139

  Dong, Rui Hua ^a   Fang, Zhong Ze ^b,c   Zhu, Liang Liang ^b   Ge, Guang Bo ^b   Li, Xiao Bao ^a   Hu, Cui Min ^c   Cao, Yun Feng ^b   Xia, Yang Liu ^b   Yang, Ling ^b   Liu, Ze Yuan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Drug drug interaction; Thienorphine; UDP glucuronosyltransferase (UGT)

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 2B7; OPIATE AGONIST; THIENORPHINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG GLUCURONIDATION; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER MICROSOME;

ANALGESICS, OPIOID; BUPRENORPHINE; GLUCURONOSYLTRANSFERASE; HUMANS; HYMECROMONE; ISOENZYMES; KINETICS; MICROSOMES, LIVER;

EID: 84870797358     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2012.706723     Document Type: Article

References (24)

1. Dong RH, Fang ZZ, Zhu LL, Liang SC, Ge GB, Yang L, Liu ZY. (2012a). Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol. Phytother Res 26:86-90.
2. Dong RH, Fang ZZ, Zhu LL, Ge GB, Yang L, Liu ZY. (2012b). Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol. Xenobiotica. doi: 10.3109/00498254.2012.682614.
3. Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L. (2010). Timedependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69:193-199.
4. Fang ZZ, Zhang YY, Wang XL, Cao YF, Huo H, Yang L. (2011a). Bioactivation of herbal constituents: simple alerts in the complex system. Expert Opin Drug Metab Toxicol 7:989-1007.
5. Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L. (2011b). Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions. Phytother Res 25:256-263.
6. Huang T, Fang ZZ, Yang L. (2010). Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDPglucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions. Pharmazie 65:919-921.
7. Innocenti F, Iyer L, Ratain MJ. (2001). Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metab Dispos 29:596-600. (Pubitemid 32275543)
8. Kiang TK, Ensom MH, Chang TK. (2005). UDPglucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106:97-132.
9. Kong Q, Qiao J, Wang X, Yuan S, Zhang Z, Gong Z, Ruan J. (2007). Simultaneous determination of thienorphine and its active metabolite thienorphine glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 859:52-61. (Pubitemid 47626086)
10. Lewis JW. (1985). Buprenorphine. Drug Alcohol Depend 14:363-372. (Pubitemid 15149057)
11. Liu CH, Liu H, Han XY, Wu B, Zhong BH, Gong ZH. (2005). Synthesis and characterization of thienorphine and its glucuronide conjugate. Synthetic Communications 35:701-710. (Pubitemid 40389511)
12. Liu Y, RaMez J, Ratain MJ. (2011). Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors. Br J Clin Pharmacol 71:917-920.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
14. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685. (Pubitemid 41345319)
15. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
16. Qu YQ, Fang ZZ, Yang L, Gao ZM, Liang R, Zhu LL, Dong PP, Zhang YY, Ge GB, Wang LM. (2011). Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol. Pharmazie 66:216-221.
17. Ritter JK. (2000). Roles of glucuronidation and UDPglucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171-193. (Pubitemid 32061059)
18. Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J. (2010). Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 24:1213-1216.
19. Uchaipichat V, Mackenzie PI, Elliot DJ, Miners JO. (2006). Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udpglucuronosyltransferases. Drug Metab Dispos 34:449-456.
20. Yu G, Yue YJ, Cui MX, Gong ZH. (2006). Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine. J Pharmacol Exp Ther 318:282-287.
21. Zhou J, Tracy TS, Remmel RP. (2011). Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors. Drug Metab Dispos 39:322-329.
22. Zhu LL, Ge GB, Zhang HB, Liu HX, He GY, Liang SC, Zhang YY, Fang ZZ, Dong PP, Finel M, Yang L. (2012a). Characterization of hepatic and intestinal glucuronidation of magnolol: application of the RAF approach to decipher the contributions of multiple UGT isoforms. Drug Metab Dispos 40:522-528.
23. Zhu LL, Ge GB, Liu Y, He GY, Liang SC, Fang ZZ, Dong PP, Cao YF, Yang L. (2012b). Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9. Xenobiotica, DOI:10.3109/0049825 4.2012.681814.
24. Zimmerman DM, Leander JD. (1990). Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J Med Chem 33:895-902. (Pubitemid 20085889)